Viewing Study NCT06976203


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-01-01 @ 5:34 PM
Study NCT ID: NCT06976203
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module